The FDA has classified a September recall of CooperVision's Sofmed Breathables Advanced Toric contact lenses as a Class II action, citing a packaging error rather than a defect in the lenses themselves. The mix-up involved carton labels that incorrectly told wearers the product was approved for extended wear, when it is intended strictly for daily use.
What went wrong with the labeling
CooperVision notified customers of the recall on Sept. 22, and the FDA added its Class II classification to the case on Oct. 22. According to the agency, the affected cartons carried "an incorrect statement on the carton packaging indicating that the product is 'Indicated for Extended Wear,'" even though the FDA has never approved this particular lens for that use. The Sofmed Breathables Advanced Toric lens, made from a silicone hydrogel material called fanfilcon A with 55% water content, is cleared only for daily wear with frequent replacement.
The FDA noted plainly that the "extended-wear statement should not have appeared on the affected carton labeling," underscoring that the problem is one of documentation, not lens design or manufacturing quality.
Scope of the recall and what a Class II label means
The recall covers 230,856 lenses distributed to eye care providers and distributors in Florida, Kentucky, and Michigan. Specific lot and 510(k) numbers tied to the affected units are listed in CooperVision's and the FDA's public recall documentation.
A Class II classification indicates that use of the mislabeled product could cause temporary or medically reversible harm, or carries a low likelihood of more serious health consequences. Importantly, this classification does not automatically mean consumers must stop using the product immediately - that determination depends on whether the manufacturer issues separate guidance. In this case, the core concern is that patients might mistakenly believe they can wear the lenses overnight or for multiple days without removal, which raises the risk of eye irritation or infection associated with improper extended wear.
Guidance for patients and providers
- Stop using or distributing lenses from the affected lot numbers if the packaging states "Indicated for Extended Wear."
- Return any affected lenses to the eye care provider, distributor, or location of purchase.
- Contact the original point of purchase with questions about returns, credit, or replacement.
The FDA has asked eye care providers to proactively reach out to patients who received the mislabeled product and direct them to return it. As of the recall report, no adverse events had been linked to the labeling error, though the FDA encourages anyone who experiences a problem to file a report through its MedWatch Adverse Event Reporting program online or by mail or fax.
Context: a separate, unrelated recall
This incident is distinct from another Class II recall affecting roughly 3,000 of CooperVision's Pearle Vision 1 Day contact lenses, initiated in August and classified by the FDA in September due to an "incorrect power" issue. The two recalls involve different products, different causes, and different affected regions, and should not be conflated when assessing risk.